The "Invisible" Patient and AI-Driven Opportunistic Screening
When you look at the sheer numbers, the US Bone Density Test Market is witnessing a quiet revolution through "opportunistic screening." In 2026, the market is no longer solely reliant on patients being specifically referred for a DEXA scan. Instead, AI-powered software is now being used to analyze standard CT scans and X-rays—originally taken for unrelated issues like abdominal...
0 Commenti 0 condivisioni 12 Views 0 Anteprima
Lifesone https://lifesone.com